213 related articles for article (PubMed ID: 16867031)
1. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
[TBL] [Abstract][Full Text] [Related]
2. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
Gauthier S; Loft H; Cummings J
Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
[TBL] [Abstract][Full Text] [Related]
3. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
Monsch AU; Giannakopoulos P;
Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
[TBL] [Abstract][Full Text] [Related]
4. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
[TBL] [Abstract][Full Text] [Related]
5. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
[TBL] [Abstract][Full Text] [Related]
6. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
8. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
[TBL] [Abstract][Full Text] [Related]
9. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
11. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
[TBL] [Abstract][Full Text] [Related]
13. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
Hamuro A; Saito S
Psychogeriatrics; 2010 Dec; 10(4):198-200. PubMed ID: 21159055
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study.
Tatsumi H; Nakaaki S; Torii K; Shinagawa Y; Watanabe N; Murata Y; Sato J; Mimura M; Furukawa TA
Psychiatry Clin Neurosci; 2009 Jun; 63(3):374-84. PubMed ID: 19566770
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients.
Herrmann N; Lanctôt KL; Eryavec G; Khan LR
J Psychopharmacol; 2004 Jun; 18(2):215-20. PubMed ID: 15260910
[TBL] [Abstract][Full Text] [Related]
16. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
[TBL] [Abstract][Full Text] [Related]
17. Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease.
Starr JM; Lonie J
Dement Geriatr Cogn Disord; 2007; 24(5):343-7. PubMed ID: 17890863
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Lim HK; Pae CU; Lee C; Lee CU
Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
[TBL] [Abstract][Full Text] [Related]
19. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
Shimabukuro J; Awata S; Matsuoka H
Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
